Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged ...
Amgen has a lot riding on an experimental obesity drug that it hopes will rival those of Eli Lilly and Novo Nordisk. But one ...
France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
Sky News has revealed thousands of people with severe obesity are being denied access to effective treatment, partly because ...
WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise ...
The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...
Achieving weight loss within a year of initiating orlistat can reduce the risk for both incident gout and recurrent gout ...
Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...
Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...
Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, according to a national survey conducted this year by Mercer, a human resources ...